Inventor · disambiguated record
Javier Ramirez
Also filed as: RAMIREZ JAVIER · RAMIREZ JAVIER ALBERTO
4 granted patents·5 pending applications·5 citations·filing 2006–2020
64Inventor score
Files withCOLPITTS TRACEY3ABBOTT LAB1ABBOTT MOLECULAR INC1CONSEJO NAC INVEST CIENT TEC1LORENZANO MENNA PABLO1
Top patents by PatentIndex Score
9 records- 0161US9347945B2Methods and marker combinations for screening for predisposition to lung cancerCOLPITTS TRACEY·Filed 2007·Granted May 24, 2016·2 cites·12 claims
- 0261US8431554B2Compound showing anti-inflammatory activity and antiviral activity, pharmaceutical compositions comprising the same, a process for obtaining the same and use of the same in the treatment of epidemic keratoconjunctivites and herpetic stromal keratisRAMIREZ JAVIER ALBERTO·Filed 2008·Granted Apr 30, 2013·2 cites·13 claims
- 0360US2015168412A1Methods And Marker Combinations For Screening For Predisposition To Lung CancerABBOTT LAB·Filed 2014·Application pending·0 cites
- 0459US9187518B2Antiangiogenic brassinosteroid compoundsCONSEJO NAC INVEST CIENT TEC·Filed 2012·Granted Nov 17, 2015·1 cites·12 claims
- 0557US2016320393A1Methods And Marker Combinations For Screening For Predisposition To Lung CancerABBOTT MOLECULAR INC·Filed 2016·Application pending·0 cites
- 0649US2012071334A1Methods And Marker Combinations For Screening For Predisposition To Lung CancerCOLPITTS TRACEY·Filed 2008·Application pending·0 cites
- 0746US9291535B2Method and apparatus for the extraction of vitamin D metabolites from human plasmaOROCHEM TECHNOLOGIES INC·Filed 2014·Granted Mar 22, 2016·0 cites·28 claims
- 0837US2022193068A1A grk2 protein inhibitor compound and a pharmaceutical composition comprising the sameLORENZANO MENNA PABLO·Filed 2020·Application pending·0 cites
- 0936US2007178504A1Methods and marker combinations for screening for predisposition to lung cancerCOLPITTS TRACEY·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Javier Ramirez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →